AARVIK THERAPEUTICS

Live / Registered — Registered (as of 27 Jan 2026)

What this means for you

Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90879874
Registration number
8118566
Mark type
Stylized text
Filed
12 Aug 2021
Published for opposition
31 May 2022
Registered
27 Jan 2026
Attorney of record
Christopher D. Olszyk, Jr.

Goods and services

  • Class 042 — Scientific and technological services: Scientific research for medical purposes in the field of cancer, infectious and neurologic diseases and disorders; research and development services in the field of antibodies; Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of mono-specific antibodies, bi-specific, multi-specific antibodies; antibody-drug conjugates, T cell, NK cell, and Macrophage engaging antibodies; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, infectious and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research development and establishment of testing specifications and procedures in the field of cancer research, and scientific research in the field of cancer diagnosis and treatment; Providing scientific research information in the field of cancer research, and providing scientific research information in the field of cancer diagnosis and treatment

Owner

Prosecution history

  • 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
  • 02 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 02 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 27 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 01 Dec 2025 — USE AMENDMENT FILED
  • 01 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
  • 21 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 21 Oct 2025 — SOU EXTENSION 5 GRANTED
  • 28 May 2025 — SOU EXTENSION 5 FILED
  • 21 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 29 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 30 Nov 2024 — SOU EXTENSION 4 GRANTED
  • 29 Nov 2024 — SOU EXTENSION 4 FILED

View this trademark record on Marksy